
John F Crowley
businessMale0.0Global Dominance: 0.00%
John F Crowley is the president of the Biotechnology Innovation Organization, a trade association representing biotechnology companies. He criticized President Trump's proposal for Most Favored Nation status in drug pricing, labeling it as a deeply flawed approach that could jeopardize funding for small- and mid-sized biotech firms and ultimately harm patient access to innovative treatments.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
John F Crowley, president of the Biotechnology Innovation Organization, called MFN status a deeply flawed proposal.
What's in it, and will it work?BBC·
United Kingdom· 2025-05-12







